BACKGROUND & AIMS: Transmural inflammation, a distinguishing feature of Crohn's disease (CD), cannot be assessed by conventional colonoscopy with mucosal biopsy. Our previous ex vivo study of histology-correlated optical coherence tomography (OCT) imaging on colectomy specimens of CD and ulcerative colitis (UC) showed that disruption of the layered structure of colon wall on OCT is an accurate marker for transmural inflammation of CD. We performed an in vivo colonoscopic OCT in patients with a clinical diagnosis of CD or UC using the previously established, histology-correlated OCT imaging criterion. METHODS: OCT was performed in 40 patients with CD (309 images) and 30 patients with UC (292 images). Corresponding endoscopic features of mucosal inflammation were documented. Two gastroenterologists blinded to endoscopic and clinical data scored the OCT images independently to assess the feature of disrupted layered structure. RESULTS: Thirty-six CD patients (90.0%) had disrupted layered structure, whereas 5 UC patients (16.7%) had disrupted layered structure (P < .001). Using the clinical diagnosis of CD or UC as the gold standard, the disrupted layered structure on OCT indicative of transmural inflammation had a diagnostic sensitivity and specificity of 90.0% (95% CI: 78.0%, 96.5%) and 83.3% (95% CI: 67.3%, 93.3%) for CD, respectively. The kappa coefficient in the interpretation of OCT images was 0.80 (95% CI: 0.75, 0.86, P < .001). CONCLUSIONS: In vivo colonoscopic OCT is feasible and accurate to detect disrupted layered structure of the colon wall indicative of transmural inflammation, providing a valuable tool to distinguish CD from UC.
BACKGROUND & AIMS:Transmural inflammation, a distinguishing feature of Crohn's disease (CD), cannot be assessed by conventional colonoscopy with mucosal biopsy. Our previous ex vivo study of histology-correlated optical coherence tomography (OCT) imaging on colectomy specimens of CD and ulcerative colitis (UC) showed that disruption of the layered structure of colon wall on OCT is an accurate marker for transmural inflammation of CD. We performed an in vivo colonoscopic OCT in patients with a clinical diagnosis of CD or UC using the previously established, histology-correlated OCT imaging criterion. METHODS: OCT was performed in 40 patients with CD (309 images) and 30 patients with UC (292 images). Corresponding endoscopic features of mucosal inflammation were documented. Two gastroenterologists blinded to endoscopic and clinical data scored the OCT images independently to assess the feature of disrupted layered structure. RESULTS: Thirty-six CDpatients (90.0%) had disrupted layered structure, whereas 5 UC patients (16.7%) had disrupted layered structure (P < .001). Using the clinical diagnosis of CD or UC as the gold standard, the disrupted layered structure on OCT indicative of transmural inflammation had a diagnostic sensitivity and specificity of 90.0% (95% CI: 78.0%, 96.5%) and 83.3% (95% CI: 67.3%, 93.3%) for CD, respectively. The kappa coefficient in the interpretation of OCT images was 0.80 (95% CI: 0.75, 0.86, P < .001). CONCLUSIONS: In vivo colonoscopic OCT is feasible and accurate to detect disrupted layered structure of the colon wall indicative of transmural inflammation, providing a valuable tool to distinguish CD from UC.
Authors: John A Evans; Brett E Bouma; Jason Bressner; Milen Shishkov; Gregory Y Lauwers; Mari Mino-Kenudson; Norman S Nishioka; Guillermo J Tearney Journal: Gastrointest Endosc Date: 2006-09-20 Impact factor: 9.427
Authors: Isaac J Pence; Dawn B Beaulieu; Sara N Horst; Xiaohong Bi; Alan J Herline; David A Schwartz; Anita Mahadevan-Jansen Journal: Biomed Opt Express Date: 2017-01-04 Impact factor: 3.732
Authors: Zhao-xiu Liu; Tom Deroche; Feza H Remzi; Jefferey P Hammel; Victor W Fazio; Run-zhou Ni; John R Goldblum; Bo Shen Journal: Surg Endosc Date: 2011-06-10 Impact factor: 4.584
Authors: Hao Lei; Laura A Johnson; Shengchun Liu; David S Moons; Teng Ma; Qifa Zhou; Michael D Rice; Jun Ni; Xueding Wang; Peter D R Higgins; Guan Xu Journal: Biomed Opt Express Date: 2016-06-27 Impact factor: 3.732
Authors: Tomoki Makino; Manu Jain; David C Montrose; Amit Aggarwal; Joshua Sterling; Brian P Bosworth; Jeffrey W Milsom; Brian D Robinson; Maria M Shevchuk; Kathy Kawaguchi; Ning Zhang; Christopher M Brown; David R Rivera; Wendy O Williams; Chris Xu; Andrew J Dannenberg; Sushmita Mukherjee Journal: Cancer Prev Res (Phila) Date: 2012-09-07
Authors: E Coron; E Auksorius; A Pieretti; M M Mahé; L Liu; C Steiger; Y Bromberg; B Bouma; G Tearney; M Neunlist; A M Goldstein Journal: Neurogastroenterol Motil Date: 2012-10-28 Impact factor: 3.598